YOUNGBLOOD DR KNEELAND
SEC insider (Form 3/4/5 filer). CIK 0001137820. Director at Light & Wonder, Inc. (ASX:LNW) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in LAS VEGAS, NV.
Companies YOUNGBLOOD DR KNEELAND has filed insider reports for
- Light & Wonder, Inc. (ASX:LNW): Director
- KPET Ultra Paceline Corp (KPET): Director
YOUNGBLOOD DR KNEELAND
CIK: 0001137820
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026ASX:LNW
Light & Wonder, Inc.
ExerciseDirect2.4K shares- - Jun 10, 2026ASX:LNW
Light & Wonder, Inc.
AwardDirectRestricted Stock Units
2.5K shares- - Jun 10, 2025LNW
Light & Wonder, Inc.
AwardDirectRestricted Stock Units
2.4K shares- - Jun 5, 2025LNW
Light & Wonder, Inc.
ExerciseDirect2.2K shares-
1-4 of 4 transactions